Status:
TERMINATED
Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Collaborating Sponsors:
Association Clinique Thérapeutique Infantile du val de Marne
Conditions:
Meningitis, Meningococcal
Sequela
Eligibility:
All Genders
Up to 17 years
Brief Summary
While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year. The objective of this research is to evaluate the sequela...
Eligibility Criteria
Inclusion
- Infants and children from 0 to 17 years old
- Having had meningitis or meningococcal purpura fulminans between 2010 and 2021
- Delay ≥ 1 year between the date of diagnosis of meningitis or purpura meningococcal fulminans and the date of inclusion in the study (signature of the informed consent)
- The holders of parental authority have read and understood the information letter and their express consent has been obtained
- Patient affiliated to a social security system (Social Security or Universal Medical Coverage)
Exclusion
- refusal to participate
Key Trial Info
Start Date :
July 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 19 2025
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04685850
Start Date
July 9 2021
End Date
May 19 2025
Last Update
June 13 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bicêtre
Le Kremlin-Bicêtre, Kremlin Bicêtre, France, 94720
2
CHU Annecy
Annecy, France, 74370
3
CHI créteil
Créteil, France, 94000
4
Centre Intercommunal de Villeneuve Saint Georges
Crosne, France, 91560